Cargando…
The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44(hi) Stem-Like NSCLC Cells
Lung cancer is among the most lethal malignancies with a high metastasis and recurrence rate, which is probably due to the existence of lung cancer stem cells (CSCs). CSCs in many tumors including non-small cell lung cancer (NSCLC) have been identified using adhesion molecular CD44, either individua...
Autores principales: | Shi, Yang, Liu, Can, Liu, Xin, Tang, Dean G., Wang, Junchen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942411/ https://www.ncbi.nlm.nih.gov/pubmed/24595209 http://dx.doi.org/10.1371/journal.pone.0090022 |
Ejemplares similares
-
Correlative analysis of miR-34b and p53 with pathological characteristics of NSCLC
por: Yang, Shuai, et al.
Publicado: (2019) -
Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis
por: Liu, Yaosheng, et al.
Publicado: (2015) -
Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Li, Jia, et al.
Publicado: (2015) -
Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Yan, Xuefei, et al.
Publicado: (2019) -
Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44
por: Liu, Can, et al.
Publicado: (2011)